PreScience Labs

Phase I

PSL's Phase I Study will be the first formal evaluation in the world of this compound. PreScience plans to enroll patients in its Phase I study at leading medical centers in the U.S. It anticipates that the first patient will be enrolled in 2015, and plans for all centers to be treating patients by mid-year.